TELCON RF PHARMACEUTICAL. Inc.

200230 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩2,165.00
+1.17%
Delayed · cached 15 min

Fair value analysis

Reported earnings per share are negative or zero, so the earnings-based models cannot produce a value.

Financial DNA score 19 / 100

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.